I have been here for five to six years like so many others. I feel lucky I got in early. ( Thanks Bourbon) I believe in this science after all the information for this period of time. The only thing that troubles me is why haven't the markets responded with a close to fair valuation. Yes, I know we didn't IPO and all that. But when this information came out seven months ago it should have taken us to a 3 to 5 billion dollar MC. imo
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Parkinson’s Disease Dementia.